Relvar Ellipta inhalation powder, pre-dispensed
Last Updated on eMC 31-May-2017 View document | GlaxoSmithKline UK Contact details
Versions
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 31-May-2017 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 6 - date of revision
Updated on 03-May-2017 and displayed until 31-May-2017
Reasons for adding or updating:
- Change to section 4 - possible side effects
- Change to section 6 - what the product looks like and pack contents
- Change to section 6 - date of revision
Updated on 08-Jul-2016 and displayed until 03-May-2017
Reasons for adding or updating:
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 22-Jan-2016 and displayed until 08-Jul-2016
Reasons for adding or updating:
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 22-Dec-2015 and displayed until 22-Jan-2016
Reasons for adding or updating:
- Change to section 4 - possible side effects
- Change to section 6 - marketing authorisation holder
- Change to section 6 - date of revision
Updated on 29-Sep-2015 and displayed until 22-Dec-2015
Reasons for adding or updating:
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 01-Jul-2015 and displayed until 29-Sep-2015
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 06-Jan-2015 and displayed until 01-Jul-2015
Reasons for adding or updating:
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 05-Jan-2015 and displayed until 06-Jan-2015
Reasons for adding or updating:
- Change to section 4 - possible side effects
Updated on 09-Jun-2014 and displayed until 05-Jan-2015
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 6 - date of revision
Updated on 08-Jan-2014 and displayed until 09-Jun-2014
Reasons for adding or updating:
- New PIL for new product
GlaxoSmithKline UK
Stockley Park West, Uxbridge, Middlesex, UB11 1BT
+44 (0)208 990 4328
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue